INBS (Intelligent Bio Solutions Inc. Common Stock) Stock Analysis - Analyst Ratings

Intelligent Bio Solutions Inc. Common Stock (INBS) is a publicly traded Healthcare sector company. As of May 21, 2026, INBS trades at $2.91 with a market cap of $8.73M and a P/E ratio of 0.34. INBS moved -11.85% today. Year to date, INBS is -74.27%; over the trailing twelve months it is -77.89%. Its 52-week range spans $2.27 to $27.50. Rallies surfaces INBS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate INBS?

The average price target is $0.00.

INBS Key Metrics

Key financial metrics for INBS
MetricValue
Price$2.91
Market Cap$8.73M
P/E Ratio0.34
EPS$8.95
Dividend Yield0.00%
52-Week High$27.50
52-Week Low$2.27
Volume169
Avg Volume0
Revenue (TTM)$3.91M
Net Income$-11.65M
Gross Margin47.25%

INBS Analyst Consensus

INBS analyst coverage data. Average price target: $0.00.

Latest INBS News

Recent INBS Insider Trades

  • Simeonidis Harry bought 50 (~$92.5) on Sep 1, 2023.
  • Simeonidis Harry bought 100 (~$192) on Aug 31, 2023.

Common questions about INBS

What do analysts rate INBS?
The average price target is $0.00.
Does Rallies show INBS price targets?
Yes. Rallies tracks INBS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is INBS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INBS. It does not provide personalized investment advice.
INBS

INBS